Apoptosis in Human Uterine Leiomyomas

Human uterine leiomyomas (fibroids) are benign neoplasms that typically occur in reproductive age and perimenopausal women. These tumors pose a significant and costly health concern for numerous women throughout the world. Alternative therapies are few, with hysterectomy being the treatment of choice by many physicians. There is a growing body of evidence suggesting that the development of leiomyomas may be influenced by numerous factors including genetic, environmental, and hormonal influences resulting in a possible failure of any number of apoptotic pathways. Understanding the role apoptosis plays in the normal regression of nascent myometrial tissue and how this failure may influence leiomyoma tumor growth may provide a better understanding of how to develop effective and less invasive treatment modalities for this disease. The following review attempts to highlight what is currently known about apoptosis in leiomyomas as compared with the normal myometrium and where future research is needed.

KEYWORDS

Leiomyomas - uterus - fibroids - apoptosis

REFERENCES

• 1 Wilcox L S, Koonin L M, Pokras R, Strauss L T, Xia Z, Peterson H B. Hysterectomy in the United States, 1988-1990.  Obstet Gynecol. 1994;  83 549-555
• 2 Marshall L M, Spiegelman D, Barbieri R L et al.. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race.  Obstet Gynecol. 1997;  90 967-973
• 3 Ross R K, Pike M C, Vessey M P, Bull D, Yeates D, Casagrande J T. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives.  Br Med J (Clin Res Ed). 1986;  293 359-362
• 4 Schwartz S M. Epidemiology of uterine leiomyomata.  Clin Obstet Gynecol. 2001;  44 316-326
• 5 Garcia Muret M P, Pujol R M, Alomar A, Calaf J, de Moragas J M. Familial leiomyomatosis cutis et uteri (Reed's syndrome).  Arch Dermatol Res. 1988;  280(suppl) S29-S32
• 6 Kjerulff K H, Guzinski G M, Langenberg P W, Stolley P D, Moye N E, Kazandjian V A. Hysterectomy and race.  Obstet Gynecol. 1993;  82 757-764
• 7 Treloar S A, Do K A, O'Connor V M, O'Connor D T, Yeo M A, Martin N G. Predictors of hysterectomy: an Australian study.  Am J Obstet Gynecol. 1999;  180 945-954
• 8 Schwartz S M, Marshall L M, Baird D D. Epidemiologic contributions to understanding the etiology of uterine leiomyomata.  Environ Health Perspect. 2000;  108(suppl 5) 821-827
• 9 Chavez N F, Stewart E A. Medical treatment of uterine fibroids.  Clin Obstet Gynecol. 2001;  44 372-384
• 10 Walker C L, Burroughs K D, Davis B, Sowell K, Everitt J I, Fuchs-Young R. Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma.  J Soc Gynecol Investig. 2000;  7 249-256
• 11 Matsuo H, Maruo T, Samoto T. Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone.  J Clin Endocrinol Metab. 1997;  82 293-299
• 12 Dixon D, Flake G P, Moore A B et al.. Cell proliferation and apoptosis in human uterine leiomyomas and myometria.  Virchows Arch. 2002;  441 53-62
• 13 Wu X, Blanck A, Olovsson M, Henriksen R, Lindblom B. Expression of Bcl-2, Bcl-x, Mcl-1, Bax and Bak in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause.  J Steroid Biochem Mol Biol. 2002;  80 77-83
• 14 Vu K, Greenspan D L, Wu T C, Zacur H A, Kurman R J. Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas.  Hum Pathol. 1998;  29 359-363
• 15 Wang Y, Matsuo H, Kurachi O, Maruo T. Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells.  Eur J Endocrinol. 2002;  146 447-456
• 16 Matsuo H, Kurachi O, Shimomura Y, Samoto T, Maruo T. Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma.  Oncology. 1999;  57(suppl 2) 49-58
• 17 Huang S C, Tang M J, Hsu K F, Cheng Y M, Chou C Y. Fas and its ligand, caspases, and bcl-2 expression in gonadotropin-releasing hormone agonist-treated uterine leiomyoma.  J Clin Endocrinol Metab. 2002;  87 4580-4586
• 18 Sedlak T W, Oltvai Z N, Yang E et al.. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax.  Proc Natl Acad Sci U S A. 1995;  92 7834-7838
• 19 Gao Z, Matsuo H, Nakago S, Kurachi O, Maruo T. p53 tumor suppressor protein content in human uterine leiomyomas and its down-regulation by 17 beta-estradiol.  J Clin Endocrinol Metab. 2002;  87 3915-3920
• 20 Wu X, Blanck A, Olovsson M, Moller B, Favini R, Lindblom B. Apoptosis, cellular proliferation and expression of p53 in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause.  Acta Obstet Gynecol Scand. 2000;  79 397-404
• 21 Baek W K, Kim D, Jung N et al.. Increased expression of cyclin G1 in leiomyoma compared with normal myometrium.  Am J Obstet Gynecol. 2003;  188 634-639
• 22 Gupta S. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (review).  Int J Oncol. 2003;  22 15-20
• 23 Haviv R, Stein R. Nerve growth factor inhibits apoptosis induced by tumor necrosis factor in PC12 cells.  J Neurosci Res. 1999;  55 269-277
• 24 Kurachi O, Matsuo H, Samoto T, Maruo T. Tumor necrosis factor-alpha expression in human uterine leiomyoma and its down-regulation by progesterone.  J Clin Endocrinol Metab. 2001;  86 2275-2280
• 25 Gao Z, Matsuo H, Wang Y, Nakago S, Maruo T. Up-regulation by IGF-I of proliferating cell nuclear antigen and Bcl-2 protein expression in human uterine leiomyoma cells.  J Clin Endocrinol Metab. 2001;  86 5593-5599
• 26 Huang J, Zou J, Xu B, Zhang Y, Chen X, Liu D. [Affect of insulin-like growth factor I and estradiol on the growth of uterine leiomyoma].  Hunan Yi Ke Da Xue Xue Bao. 1999;  24 29-32
• 27 Gerdes J, Li L, Schlueter C et al.. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.  Am J Pathol. 1991;  138 867-873
• 28 Englund K, Lindblom B, Carlstrom K, Gustavsson I, Sjoblom P, Blanck A. Gene expression and tissue concentrations of IGF-I in human myometrium and fibroids under different hormonal conditions.  Mol Hum Reprod. 2000;  6 915-920
• 29 Mizutani T, Sugihara A, Nakamuro K, Terada N. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate).  J Clin Endocrinol Metab. 1998;  83 1253-1255
• 30 Shimomura Y, Matsuo H, Samoto T, Maruo T. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma.  J Clin Endocrinol Metab. 1998;  83 2192-2198
• 31 Maruo T, Matsuo H, Samoto T et al.. Effects of progesterone on uterine leiomyoma growth and apoptosis.  Steroids. 2000;  65 585-592